NASDAQ : CBLL
CeriBell, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 27.82 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.03B |
| Enterprise Value | 927.32M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 38.38M |
| Shares Outstanding | 38.38M |
| Shares Change (YoY) | +37.38% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 5.50% |
| Owned by Institutions (%) | 70.83% |
| Float | 26.55M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.15 |
| Forward PS | 7.91 |
| PB Ratio | 8.03 |
| P/TBV Ratio | 8.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 9.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.18 |
| Quick Ratio | 8.45 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.57 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -43.93% |
| Return on Assets (ROA) | -23.38% |
| Return on Invested Capital (ROIC) | -25.43% |
| Return on Capital Employed (ROCE) | -46.91% |
| Weighted Average Cost of Capital (WACC) | 9.31% |
| Revenue Per Employee | $311,817 |
| Profits Per Employee | -$201,826 |
| Employee Count | 327 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.78 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +136.49% |
| 50-Day Moving Average | 24.98 |
| 200-Day Moving Average | 20.80 |
| Relative Strength Index (RSI) | 56.00 |
| Average Volume (20 Days) | 556,566 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.16M |
| Short Previous Month | 2.02M |
| Short % of Shares Out | 5.62% |
| Short % of Float | 8.12% |
| Short Ratio (days to cover) | 5.05 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 101.96M |
| Gross Profit | 90.65M |
| Operating Income | -69.97M |
| Pretax Income | -66.00M |
| Net Income | -66.00M |
| EBITDA | -68.80M |
| EBIT | -69.97M |
| Loss Per Share | -$1.76 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 129.26M |
| Total Debt | 21.91M |
| Net Cash | 107.35M |
| Net Cash Per Share | $2.80 |
| Equity (Book Value) | 128.31M |
| Book Value Per Share | 3.36 |
| Working Capital | 140.65M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -54.03M |
| Capital Expenditures | -2.07M |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | n/a |
| Free Cash Flow | -56.10M |
| FCF Per Share | -$1.46 |
Margins
| Measure | Value |
|---|
| Gross Margin | 88.90% |
| Operating Margin | -68.62% |
| Pretax Margin | -64.73% |
| Profit Margin | -64.73% |
| EBITDA Margin | -67.48% |
| EBIT Margin | -68.62% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -37.38% |
| Shareholder Yield | -37.38% |
| Earnings Yield | -6.54% |
| FCF Yield | -5.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $28.57 |
| Price Target Difference | 5.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 28.23% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 8.02 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |